New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 6, 2014
08:41 EDTBCLIBrainStorm Cell announces first patient enrollment in Phase II ALS trial
BrainStorm Cell announced that the first patient was enrolled in its Phase II ALS trial at Massachusetts General Hospital. BrainStorm's Phase II trial is a randomized, double-blind, placebo controlled multi-center study designed to evaluate the safety and efficacy of transplantation of Autologous Mesenchymal Stem Cells Secreting Neurotrophic Factors in 48 ALS patients. The trial is also being conducted at the University of Massachusetts Memorial Hospital and the Mayo Clinic in Rochester, Minnesota.
News For BCLI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 26, 2015
10:50 EDTBCLIBrainStorm management to meet with Maxim
Subscribe for More Information
08:27 EDTBCLIBrainStorm reports Q4 EPS (18c), one estimate (15c)
Subscribe for More Information
March 25, 2015
07:16 EDTBCLIPiper Jaffray and the Alliance for Regenerative Medicine co-host conference
3rd Annual Regenerative Medicine Investor Day is being held in New York on March 25 with webcasted company presentations to begin at 8 am; not all company presentations may be webcasted. Webcast Link

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use